75 patients were diagnosed with liver cirrhosis (LC) and hepato cellular carcinoma (HCC) are divided into 3 groups: Group 1: 30patients of LC together HCC with digestive bleeding; Group 2: 30 parients of LC with digestive bleeding; Group 3: 15 patients of LC with high risk of digestive bleeding from oesophageal varices. The haemostasis success in Group 1 (LC accompanied by HCC) and Group 2 (LC with digestive bleeding due to oesophageal varices) are 73.3% and 93.3%, respectively. The success of breaking the cluster of oesophageal varices in Group 2 (LC) and Group 3 (LC with high risk of digestive bleeding and treated by prophylactic ligation) are 73.3% and 80%, respectively. The rate of rebleeding in Group 2 and 3 after a year is 20% and 13.3%, respectively.
Fibrosis ; Liver ; Carcinoma, Hepatocellular

From June 2001 to March 2004, Military Hospital 108 had performed flexible colonoscopy on 1056 subjects and had detected 18 cases (12 males, 6 females) of atypical ulcerous colitis. Clinical manifestations: bleeding stool, irregular diarrhoea or constifution, abdomen pain, weight loss... were most usual signs. Paraclinical signs occurred prevalently only in patients with numberous acute lesions in colon. 15/18 patients (83.4%) tolarated corticoid and salazopirin. 13/15 patients recovered completely without recurrence and without colon damage in colonoscopy. 5/18 patients (27.7%) was in acute stage.
Diagnosis ; Therapeutics ; Colitis

The esophageal venous ligation in patients with cirrhosis accompanying the esophageal varices. The efficacy of esophageal venous ligation related closely (p=0,05) with the liver failure level. There was no relation between efficacy of technique with level of esophageal venous varices.
Fibrosis ; Ligation

A study on 97 patients with polyps diagnosed by endoscopy in central army hospital during 2000-2002 has shown that male/female (69/28), average ages (50), patients with one polyp, 2 polyps, 3 polyps, 4 polyps, 7 polyps and 8 polyps were 78, 15, 1, 1,1 and (1) respectively. The symptoms comprised abdominal pain (56%), dyspepsia (50%) blood and mucosa in feces (13%). Polyps concentrated in peripheral colon (43.80%). The rate of patients diagnosed early accounted for 4.2%
Colonic Polyps ; diagnosis

20 patients selected from 60 patients with hepatocellular carcinoma who treated by transcatheter oil chemoembolization (TOCE). The patients diagnosed by cytology or history, with size of tumor (5cm), without portal venous thrombosis. The results have shown that the rate of ephafetoprotein (AFP)- L3 after the treatment by TOCE related closely with relapsing time of cancer and survival duration and image of CT scanner after the treatment.
Carcinoma, Hepatocellular ; Chemoembolization, Therapeutics

A study on 523 patients with hepatocellular carcinoma in Central Army hospital during 1994-2002 has shown that average ages was 52,4+/- 13,2. The main etiology of hepatocellular carcinoma was hepatitis B virus. The survival duration in 5 groups of patients with hepatocellular carcinoma treated with PEIT, TOCE, surgery, chemotherapy and symptomatic treatment were 19,67; 11,3; 7; 9,2 and 2,7 months, respectively
Carcinoma, Hepatocellular ; Hepatitis B virus

A study was carried out on 40 hepatocellular carcinoma patients who were divided into 2 groups: 1st group (n=27) with AFP-L3<15% after treated by transcatheter oil chemoembolization (TOCE); 2nd group (n=13) with AFP-L3>15%. Results: the mean value of AFP-L3 in the 110 HCC patients was 54.623.7%, significantly higher (p<0.001) than the value in CLD (11.23.1%). When cut-off level was set 15% for AFP-L3, the sensitivity was 96.4%, and the specificity was 95%. The survival rates after 12 and 18 months of TOCE were 88.9% and 63% in the 1st group with AFP-L3<15% and 38.5% and 15.3% in the 2nd group with AFP-L3>15%, respectively. The recurrence of HCC for 1st and 2nd group were 10.23.5 months and 12.01.7 months, respectively
Carcinoma, Hepatocellular ; Therapeutics ; Diagnosis ; alpha-Fetoproteins

3 cases of digestion tract tuberculosis treated in Hospital 108 were presented. The first was operated because of intestinal obstruction, the second because of severe gastrointestinal bleeding, but biopsy showed that these two patients were treated intensively by antituberculosis chemotherapy with good success. The third was diagnosed and treated very lately loading to unsatisfied results. Therefore, it should be tried to treat with antituberculosis drug initially
Tuberculosis ; Digestion ; Diseases ; Tuberculosis, Gastrointestinal ; diagnosis ; Therapeutics

The study carries on 84 patients diagnosed cirrhosis. These patients were taken endoscopy to determine be esophagus varicosity. The result showed the risque of creation of varicosity knot is 30% in recoverable cirrhosis patients and 60% in no recoverable group. The varicosity knot has tendency filling out from 10 to 25%. The rate of appearance of varicosity knot is 8-10% every year. The risque factors: quantity of glomerule decreased on 30/84 patients with quantity of glomerule <140.000/mm, risque of esophagus varicosity is 83,33% on patients with spleenomegaly (p<0.001). However, the ascites and level of cirrhosis influences also to create esophagus varicosity knot
Liver ; Fibrosis ; Diseases

The study carries on 30 patients with hepatocellular carcinoma treated by embolism liver artery by thrombosis. Following clinical and laboratory on form includes: anamnesis, medical history, symptom and entity, immune, biochemical, endoscope. The result relies on scale of child-pugh A/B/C = 8/18/4. The result of hemostatic: good 73.3%, failed 26.6%. Association between the result of treatment and esophageal varices: the rate death of patients with esophageal varices 3 degree is 87.3%. Sign of clinical and paraclinical of hepatocellular carcinoma complicating liver cirrhosis and bleeding due to rupture of esophageal vein is also grave stage of disease. The effect hemostatic of esophageal varices knot using knot method on hepatocellular carcinoma is 73.3%. The death rate associated to varix level and red mark of esophageal vein
liver ; Sclerosis ; Carcinoma